"A good opportunity for scientists, drug developers and patient advocates to meet and discuss current issues in rare kidney diseases"
"The breadth across both preclinical and clinical hot topics was excellent, as was the quality of the speakers' presentations and the chairpersons' moderation"
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok